Tiny, I think you have a tiny brain. Tiny brain, tiny ____
Best of luck with your short position. You will need a ton of luck. But that is generally the case with dimwits, they need a lot of luck to make it through life.
Yes, my bios mostly down, with a couple of exceptions, between 1 and 4 % today. The sector rolled mid day yesterday and continued into today. Have not seen a great explanation as to why but bio has been ridiculous for a couple of years. Nothing goes straight up
Still holding a small position here so have not been keeping up. It appears everything is status quo with the company providing the drug but the stock is basically dead in the water. My assumption is that this stock has peaked until and if it wins the court case. if SIGA wins the stock will go up to whatever the additional NPV of the drug is if it doesn't have to share it, cal it $6, but that's it. To put it another way, this company has no more value to add to shareholders other than additional revenue from NOT having to share the cash with the other company. Basically holding the stock for upside at this point is strictly betting on a court win for SIGA. Anyone look at it differently?
J4185, You would need a subscription to IMS or Symphony. I get the latter thru our Bloomberg terminal (as opposed to the Bloomberg website)
Fun with numbers. At the current growth rate in 13 weeks we are at over 2 million/week. :-)
You are correct OW. Pete only said "early March" on the call. So, for all we know, they could be in there today.
Familiar with that. Cracking down on these absurd cases is long overdue. The Pomerantz law firm would sue a senior citizen if they slipped using a walker and knocked into one of their attorneys
Wait from OSIR press release..really? With $24 M in revenue???? The LEADING company? Funny
Osiris Therapeutics, Inc. (OSIR) the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets, announced today its results for the fourth quarter and full year ended December 31, 2013.
Funny smelly. Yeah, MDXG is an odd intraday mover. But like you said, I only care where the stock trades at the end of this year or next year.
how_bout., let me re-phrase. I meant to say no way 40% Amniofix injectable...that is whay the company said was no more than 15% of its business and it is the injectable that is the subject of the FDA debate